TURATO, CRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 385
EU - Europa 176
AS - Asia 84
SA - Sud America 18
Totale 663
Nazione #
US - Stati Uniti d'America 382
IE - Irlanda 79
IT - Italia 65
CN - Cina 63
BR - Brasile 18
FI - Finlandia 11
JP - Giappone 11
SG - Singapore 10
BE - Belgio 7
DE - Germania 6
SE - Svezia 4
CA - Canada 3
FR - Francia 1
LT - Lituania 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 663
Città #
Chandler 94
Boardman 84
Dublin 77
Shanghai 51
Ashburn 33
New York 21
Petrópolis 15
Helsinki 11
Pavia 11
Tokyo 9
Brussels 7
Lawrence 7
Milan 7
Princeton 7
Mira 6
Padova 6
Singapore 6
Chicago 5
Medford 5
Washington 5
Wilmington 5
Moncalieri 4
Seattle 4
Travaco Siccomario 4
Des Moines 3
Imbersago 3
Niterói 3
Toronto 3
Cittadella 2
Cork 2
Lagosanto 2
Munich 2
Urbana 2
Verona 2
West Jordan 2
Anshan 1
Beijing 1
Borås 1
Brescia 1
Cagliari 1
Changchun 1
Frankfurt am Main 1
Guangzhou 1
Handan 1
Moscow 1
Nagoya 1
Piscataway 1
Qingdao 1
Rovigo 1
Rutigliano 1
Scottsdale 1
Sendai 1
Serina 1
Shenzhen 1
Xuzhou 1
Zelo Buon Persico 1
Totale 531
Nome #
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 36
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 36
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis 32
Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure 32
SERPINB3 modulates TGF-beta expression in chronic liver disease 32
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 31
Prone positioning is safe and may reduce the rate of intubation in selected covid-19 patients receiving high-flow nasal oxygen therapy 30
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis 29
Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells 28
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 28
Model-based analysis of patient-derived organoids for evaluating anticancer drugs 25
ULTRAFINE GOLD NANOPARTICLES CONJUGATED WITH PRES1 PEPTIDE OF HEPATITIS B VIRUS ENVELOPE PROTEIN TARGETING HEPATOMA CELLS 23
Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma 19
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 19
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 16
VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference 15
Inibitore di SerpinB3 per il trattamento della progressione di malattie croniche fibrosanti e di tumori primitivi 15
Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment 13
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 10
SerpinB3 administration protects liver against ischemia-reperfusion injury 10
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection 10
Characterization of the new isoform of squamous cell carcinoma antigen-1 (SCCA-PD) detected in hepatocellular carcinoma 10
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 10
The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis 9
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition 9
Changes in gene expression of cytochrome P-450 in liver, kidney and aorta of cirrhotic rats 9
LEADING ROLE OF SERPINB3 IN MOLECULAR SIGNATURES OF WORSE PROGNOSIS IN HEPATOCELLULAR CARCINOMA 9
Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment 9
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 8
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells 8
Liver Organoids as an In Vitro Model to Study Primary Liver Cancer 7
Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells 7
Effect of a passive exhalation port on tracheostomy ventilation in amyotrophic lateral sclerosis patients: A randomized controlled trial 7
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 7
High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis 7
ROLE OF MICROGLIAL ACTIVATION VIA SERPINB3 IN EXPERIMENTAL ACUTE HEPATIC ENCEPHALOPATY 7
MicroRNAs and SerpinB3 in hepatocellular carcinoma 6
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 6
MODULATION OF P35 SIGNALING BY SERPINB3 UNDER GENOTOXIC CONDITIONS 6
Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment 6
Erratum: SERPINB3 is associated with longer survival in transgenic mice (Scientific Reports (2013) 3 (3056) DOI: 10.1038/srep03056) 6
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 5
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets 5
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 5
Hepatic progenitor cells express SerpinB3 5
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 5
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice 5
Serpinb3 is overexpressed in the liver in presence of iron overload 5
Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice 4
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats 4
SERPINB3 is associated with longer survival in transgenic mice 4
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I 4
Increased antiprotease activity of the SerpinB3 polymorphic variant SCCA-PD 4
Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbation 4
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 3
Liver pro-oncogenic potential of SERPINB3 3
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 2
Nintedanib treatment for idiopathic pulmonary fibrosis patients who have been switched from pirfenidone therapy: A retrospective case series study 2
Non-Invasive Ventilation for Acute Respiratory Failure in Duchenne Muscular Dystrophy Patients 2
Inhibition of Epoxyeicosatrienoic Acid Production in Rats With Cirrhosis Has Beneficial Effects on Portal Hypertension by Reducing Splanchnic Vasodilation 2
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker 2
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 2
SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3) 2
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma 2
Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients 2
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 2
Totale 727
Categoria #
all - tutte 6.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 8 0 0 1 0 0
2021/202229 0 0 0 0 0 0 0 1 2 2 8 16
2022/2023272 16 20 3 27 16 27 0 12 87 1 10 53
2023/2024328 14 71 24 19 42 50 35 7 2 8 23 33
2024/202589 13 67 9 0 0 0 0 0 0 0 0 0
Totale 727